Connexin43 and Myocardial Ischemia-Reperfusion Injury

Title:Connexin43 and Myocardial Ischemia-Reperfusion Injury

Volume: 18 Issue: 1

Author(s): Lingyun Zu, Ningxin Wen, Changjie Liu, Mingming Zhao and Lemin Zheng*

Affiliation:

• The Department of Cardiology, Peking University Third Hospital, Beijing 100191, China; Institute of Cardiovaslular Sciences, Peking University Health Science Center, Beijing 100191,China

Keywords: Gap junction, connexin 43, myocardial ischemia/reperfusion, electrophysiology, polypeptide, endothelial cells.

Abstract: Background: Recently, the treatment and prevention of ischemic cardiomyopathy is one of the emerging research topics in the cardiovascular field. Gap junction is the basic structure of cardiac electrophysiology. Connexin is the basic unit of gap junctions. Connexin43(CX43) is the most abundant member of Cx family in the heart, the normal expression of Cx43 is important for heart development, electrically coupled cardiomyocytes activities and coordination of myocardial function. The connection between Cx43 and myocardial ischemia/reperfusion or reperfusion injury has become the focus of current research.

Methods: We undertook a structured search of bibliographic database for peer-reviewed research literature using a focused review question and inclusion/exclusion criteria. The quality of retrieved papers was appraised using standard tools. The characteristics of screened papers were described, and a deductive qualitative content analysis methodology was applied to analyze the interventions and findings of included studies using a conceptual framework.

Results: Twenty-one papers were included in the review, eight papers outlined the relationship of Cx43 and reperfusion arrhythmias. Eight papers pointed out the effect on the infarct size of Cx43.

Conclusion: The findings of this review confirm that Cx43 is the most abundant member of Cx family in the heart and is vital for myocardial protection during ischemia/reperfusion process and for ischemia/reperfusion injury. Many of its mechanism are still not very clear and require future research in the future.

Cite this article as:

Zu Lingyun, Wen Ningxin, Liu Changjie, Zhao Mingming and Zheng Lemin*, Connexin43 and Myocardial Ischemia-Reperfusion Injury, Cardiovascular & Hematological Disorders-Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/1871529X16666161227143644